# Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

> **NCT07210619** · — · AVAILABLE · sponsor: **Regenerative Ocular Immunobiologics LLC**

## Conditions studied

- oGVHD

## Interventions

- **DRUG:** d-MAPPS

## Key facts

- **NCT ID:** NCT07210619
- **Lead sponsor:** Regenerative Ocular Immunobiologics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07210619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07210619, "Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07210619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*